Cavai AS was founded in December 2017 with the goal of revolutionizing online advertising. User experiences have largely been neglected on the web, and Cavai saw early on that chatbot technology, which has initially been used in customer service, could be a wonderfully good advertising product. Usually, chatbot technology is used as customer service on its own website, while Cavai's platform is built to be able to use chatbot technology on millions of websites for contextual advertising. The team today consists of 15 people, and the product has been launched in Norway, Finland, Sweden and the UK with 50 paying customers. Customers are very pleased and report that Cavai's technology is having a very good effect on completed advertising campaigns. Cavai will have its first month of positive operating results in October and looks to have sales of around 3 million in 2019. Next year will be a big growth year, where we have budgeted with a turnover of NOK 41 million. This growth has also been discussed by Finansavisen, where as part of Finansavisen's web-TV series "Vext", Cavai filmed his meeting with advertising legend Sir Marting Sorell in London. For more information, see https://finansavisen.no/vext/tech/2019/10/23/7465643/chatbot-company-cavai-2020-blir-the-store-growst>  To finance further growth, we are now running a seed funding round of NOK 9.5 - 15 million. The company is priced at NOK 60 million pre-money. For more information see the investor summary, investor presentation and subscription form attached.

We develop a digital platform that will help customers, both private and business, to get quick, professional, competitive, and fully transparent renovation services for apartments. Our tool has a project management system, the possibility for the financing of renovation, payment solution, insurance, resolution center, task delegation, and material handling, in addition to the quick order process with defined packages and styles you will need. We have 20 years of experience in the renovation of flats, renovated more than 150 apartments, and have contractors on the team. Our MVP is now finished, and we will start development soon on the complete solution, covering all functionalities. We are looking for investors.

Mystore.no is the leading in E­commerce platform provider in Norway. We handle orders for several billions norwegian kroner from more than 1500 webshops. In addition to being a platform provider Mystore.no provides cloud based point of sales solutions and specializes in marketing for online shopping. Mystore.no was established in 2006 and have the last 10 years worked with services related to commerce. Mystore.no provides flexible and scalable E­commerce solutions that fits both small companies and larger corporations. Mystore.no's goal is to make commerce easy and help its customers to achieve success. Mystore.no currently consists of 30 full time employees located in the head office at Tromsø, Oslo, Fredrikstad and Serbia.

70% of all processes of change fail. We believe that is because it lacks the practical implementation, and thats were we come in. We create engaging games based upon the businesses wanted culture and goals. We at Someday are tired of all the talk from sustainability to remote work to employee engagement and there are so little effort. We wanted to do something about that and we gathered the experience from our times as CEOs, trainers and UX and came up with Someday Business

Cloud-native microenvironment control for developing & scaling complex cell models. We offer solutions for vertically integrating 2D and 3D assays into your workflow, all the while you maintain real-time control over relevant readouts and variables. Find out more on www.vitroscope.no or reach out under contact@vitroscope.no

Modern, nobel-prize winning research shows that hardly any traditional investment funds are adding any value beyond what fully automated strategies can do. NorQuant's mission is to help private and professional investors achieve higher returns at lower costs through a scientific, rules-based, 100% transparent approach. We feel we are off to a good start: - We are helping our first pilot customer, one of Norway's largest family offices, implement factor-based analysis - We have been selected as one of ten fintech-startups for TheFactory.no Fall18 program, out of more than 200 applications

Alfa Audio Solutions AS is a competitive service-oriented company with long and solid experience in audiovisual solutions. With over 30 years of work in this field, we offer smart, user-friendly and reliable AV solutions, focusing on customer needs and wishes. Our services are aimed at businesses, businesses and the private market. We offer everything from simple installations to complex meeting room solutions. Video conferencing systems with Skype for Business, information screens and digital signage for your advertising message. Interactive tables for teaching and classrooms.

We have created a powerful tool for marketing and promoting real estate. Promo will help to streamline the purchase-/sales process. Our package is providing the buyer / tenant a total view of the property, its possibilities in terms of spacing, room connections, landscapes etc. We are using professional real estate agents who create a voice-over so that our video will be as close to a physical listing as possible. The viewer can watch our content anywhere or anytime! We are aiming for both commercial property, private property, sales and rent.

ExperWELL AS was established in 2016 by an innovative group of Ph.D. scientists and engineering professionals in resin technology and services for the oil and gas industry. Our focus is to be reliable, competent, innovative, and flexible. Our head office is in Norway. ExperWELL® today has different partners and agents in different countries. Our vision is to be the world leader in resin products & services for downhole applications in the oil and gas industry. Our mission is to provide eternal good barriers from innovating, environment-friendly resin. ExperWELL®’s strength lies in its experienced Ph.D. scientists who have many years of experience in resin product development and realization, as well as its experienced professional engineers in an understanding of oil & gas reservoir description and flow dynamics leading to individual well and field production performance. We are proud of what we do and strive for success with our passionate team of dedicated people. ExperWELL®’s Top Management Team always knows that the highest importance is the environment as well as the Health and Safety of our staff, persons working with our products and on our behalf, and anyone else who may be related to our operations. That is why our product development and realization is focused on GREEN and environment-friendly products which eliminate adverse effects on the environment and personnel. The Company aims to develop our proprietary main products which are safe to use as household goods.

Infopix has developed a complete solution for distributing useful information through digital information screens. We use small web-based computers like ChromeBit and also have integration with other slideshow-based platforms. We provide live data from different providers like news, weather, and flights. stocks, currencies, culture, movies, tourist information, events, and more, with customizable playlists per screen

At Vitaloop, we are working on giving you clean water everywhere. We make it whole again, removing substances and pollution left by our actions. In a rapidly changing world, Vitaloop will be insurance, proven access to the one thing no one can exist without – clean, fresh, and healthy water. Our go-to-market product is called VITALOOP ORIGIN and is a ground-breaking, patented, high-tech water cleaning bottle that can remove almost everything harmful, manufactured and caused by climate change. It's your own mobile water filtration station using the revolutionary nanomaterial Graphene. It runs by a powerful pump and a rechargeable battery that will clean 450 ml of water in 60 seconds. Vitaloop Origin provides true independence wherever and whenever. VITALOOP- Water restored.

UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.